IPI Journal
@ipimediaworld
Followers
117
Following
44
Statuses
2K
IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare.
London, England
Joined April 2016
Canton of Geneva supports Connect in Pharma 2023 Geneva’s position as a leading European...
0
0
1
AstraZeneca’s Tagrisso delivers positive results The company’s phase 3 study showed trea...
0
0
0
Connect in Pharma launches partnerships for global health innovation Sciad Newswire / Connect in Pharma anno...
0
0
0
ELRIG UK Appoints Nick Clare to Board as Vendor Strategy Work Group Lead The European Laboratory Research & ...
0
0
0
First patient dosed in pivotal CureVac flu vaccine study Modified influenza vaccine candidates h...
0
0
0
Positive opinion for Gilead’s Hepcludex The vital recommendation ensures market...
0
0
0
Endogena finalises enrolment for retinitis pigmentosa trial The treatment is a small molecule that ...
0
0
0
Ginkgo Bioworks, Boehringer Ingelheim partner on breakthrough therapies Ginkgo Bioworks, a Boston-based biotech...
0
0
0
Novavax to reduce workforce by 25% Maryland-based vaccine maker Novavax an...
0
0
0
Roche bets on Zion HER2 brain metastases prospect Roche has acquired the global rights to...
0
0
0
Explore The Latest Trends At PHARMAP 2023 Digital transformation, AI, Big Data an...
0
0
2
VYNE and Tay Therapeutics reach licence agreement The deal involves an oral BET inhibitor...
0
0
0
SporeGen and Destiny advance research collaboration The duo has partnered on developing a b...
0
0
0
NICE approves expanded use of Yescarta and Tecartus Kite’s two CAR T-Cell therapies involve...
0
0
0
Positive CHMP opinion for UCB’s bimekizumab Therapy concerns the treatment of adult...
0
0
0
King's College London and Grünenthal join forces to ease pain Duo will collaborate to develop pluripo...
0
0
0